Literature DB >> 21749290

Polymers in small-interfering RNA delivery.

Kaushik Singha1, Ran Namgung, Won Jong Kim.   

Abstract

This review will cover the current strategies that are being adopted to efficiently deliver small interfering RNA using nonviral vectors, including the use of polymers such as polyethylenimine, poly(lactic-co-glycolic acid), polypeptides, chitosan, cyclodextrin, dendrimers, and polymers-containing different nanoparticles. The article will provide a brief and concise account of underlying principle of these polymeric vectors and their structural and functional modifications which were intended to serve different purposes to affect efficient therapeutic outcome of small-interfering RNA delivery. The modifications of these polymeric vectors will be discussed with reference to stimuli-responsiveness, target specific delivery, and incorporation of nanoconstructs such as carbon nanotubes, gold nanoparticles, and silica nanoparticles. The emergence of small-interfering RNA as the potential therapeutic agent and its mode of action will also be mentioned in a nutshell.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21749290      PMCID: PMC3198620          DOI: 10.1089/nat.2011.0293

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  126 in total

1.  Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems.

Authors:  Brian G Trewyn; Supratim Giri; Igor I Slowing; Victor S-Y Lin
Journal:  Chem Commun (Camb)       Date:  2007-03-20       Impact factor: 6.222

2.  Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery.

Authors:  Kohei Tahara; Takeshi Sakai; Hiromitsu Yamamoto; Hirofumi Takeuchi; Yoshiaki Kawashima
Journal:  Int J Pharm       Date:  2007-11-09       Impact factor: 5.875

3.  Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo.

Authors:  X-Y Niu; Z-L Peng; W-Q Duan; H Wang; P Wang
Journal:  Int J Gynecol Cancer       Date:  2006 Mar-Apr       Impact factor: 3.437

4.  Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.

Authors:  Jyotsnabaran Halder; Aparna A Kamat; Charles N Landen; Liz Y Han; Susan K Lutgendorf; Yvonne G Lin; William M Merritt; Nicholas B Jennings; Arturo Chavez-Reyes; Robert L Coleman; David M Gershenson; Rosemarie Schmandt; Steven W Cole; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Clin Cancer Res       Date:  2006-08-15       Impact factor: 12.531

Review 5.  Nucleic acid delivery with chitosan hydroxybenzotriazole.

Authors:  Praneet Opanasopit; Sunee Techaarpornkul; Theerasak Rojanarata; Tanasait Ngawhirunpat; Uracha Ruktanonchai
Journal:  Oligonucleotides       Date:  2010-06

6.  Efficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapy.

Authors:  Won Jong Kim; Chien-Wen Chang; Minhyung Lee; Sung Wan Kim
Journal:  J Control Release       Date:  2007-01-09       Impact factor: 9.776

7.  PAMAM dendrimers mediate siRNA delivery to target Hsp27 and produce potent antiproliferative effects on prostate cancer cells.

Authors:  Xiao-Xuan Liu; Palma Rocchi; Fan-Qi Qu; Shu-Quan Zheng; Zi-Cai Liang; Martin Gleave; Juan Iovanna; Ling Peng
Journal:  ChemMedChem       Date:  2009-08       Impact factor: 3.466

8.  Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology.

Authors:  Chun-Fang Xia; Yufeng Zhang; Yun Zhang; Ruben J Boado; William M Pardridge
Journal:  Pharm Res       Date:  2007-10-11       Impact factor: 4.200

9.  Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits.

Authors:  M DiFiglia; M Sena-Esteves; K Chase; E Sapp; E Pfister; M Sass; J Yoder; P Reeves; R K Pandey; K G Rajeev; M Manoharan; D W Y Sah; P D Zamore; N Aronin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-16       Impact factor: 11.205

10.  Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro.

Authors:  Amy C Richards Grayson; Anne M Doody; David Putnam
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.580

View more
  56 in total

Review 1.  High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

Authors:  Rui Kuai; Dan Li; Y Eugene Chen; James J Moon; Anna Schwendeman
Journal:  ACS Nano       Date:  2016-02-25       Impact factor: 15.881

Review 2.  Delivery materials for siRNA therapeutics.

Authors:  Rosemary Kanasty; Joseph Robert Dorkin; Arturo Vegas; Daniel Anderson
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

3.  Chitosan-based hybrid nanocomplex for siRNA delivery and its application for cancer therapy.

Authors:  Min-Hyo Ki; Ji-Eon Kim; Young-Nam Lee; Sang Myoung Noh; Sung-Won An; Hyun-Jong Cho; Dae-Duk Kim
Journal:  Pharm Res       Date:  2014-05-24       Impact factor: 4.200

Review 4.  Micro and nanoparticle drug delivery systems for preventing allotransplant rejection.

Authors:  James D Fisher; Abhinav P Acharya; Steven R Little
Journal:  Clin Immunol       Date:  2015-05-01       Impact factor: 3.969

Review 5.  The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.

Authors:  Ricardo Titze-de-Almeida; Catherine David; Simoneide Souza Titze-de-Almeida
Journal:  Pharm Res       Date:  2017-04-07       Impact factor: 4.200

Review 6.  Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology.

Authors:  Peixuan Guo; Farzin Haque; Brent Hallahan; Randall Reif; Hui Li
Journal:  Nucleic Acid Ther       Date:  2012-08       Impact factor: 5.486

Review 7.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

8.  Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.

Authors:  Mar Creixell; Nicholas A Peppas
Journal:  Nano Today       Date:  2012-08-01       Impact factor: 20.722

Review 9.  Nano-ART and NeuroAIDS.

Authors:  Malay K Das; Anupam Sarma; Tapash Chakraborty
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

10.  The co-delivery of oxaliplatin abrogates the immunogenic response to PEGylated siRNA-lipoplex.

Authors:  Eman Alaaeldin; Amr S Abu Lila; Naoto Moriyoshi; Hatem A Sarhan; Tatsuhiro Ishida; Khaled A Khaled; Hiroshi Kiwada
Journal:  Pharm Res       Date:  2013-05-15       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.